Esports organiser and production company ESL Gaming has announced a new mobile esports ecosystem covering North…
Month: March 2021
Evil Geniuses unveils partnership with Elysian Brewing
North American esports organisation Evil Geniuses has announced a partnership with American brewery Elysian Brewing. The…
Green & Transformative Tech Startup FuelGems Raises $900K
AUSTIN, Texas–(BUSINESS WIRE)–GreenTech startup FuelGems announced the completion of a successful funding round that raised a…
Massive ship blocking the Suez Canal brings billions of dollars in trade to a standstill
An excavator attempts to free stranded container ship Ever Given, one of the world’s largest container…
British electric vehicle firm Arrival sinks in SPAC debut
Arrival LONDON — British electric vehicle manufacturer Arrival began trading on the Nasdaq Thursday following a…
SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Universal Electronics Inc. (UEI) (NASDAQ: UEIC), the global leader in universal control and sensing…
Cargo ship blocking Suez Canal could take weeks to move
Stranded container ship Ever Given, one of the world’s largest container ships, is seen after it…
Holberton raises $20M as it pivots to become an edtech SaaS company
Holberton, the education startup that started out as a coding school in San Francisco and today…
S&P 500 falls as stock market continues March churn
The S&P 500 dipped on Thursday, continuing its volatile run in March as the rally to…
Extra Crunch members get unlimited access to 12M stock images for $99 per year
We’re excited to announce that we’ve partnered with Yay Images for a new Extra Crunch Partner…
Brii Biosciencesが1億5500万米ドルのシリーズC資金調達を完了
米ノースカロライナ州ダーラム & 北京–(BUSINESS WIRE)–（ビジネスワイヤ） — 未充足の重要な医療ニーズを有し、公衆衛生に大きな負担をもたらす疾患に対する革新的な治療薬の開発を手掛ける多国籍企業のBrii Biosciences（Brii Bio）は本日、1億5500万米ドルのシリーズC資金調達を完了したと発表しました。今回の資金調達には、既存および新規の投資企業が参加し、インベスコ・デベロッピング・マーケッツ・ファンドが主導したものです。GICと別の世界的に有力な投資管理組織が多額の追加資金を提供し、続いてレイク・ブルー・キャピタルとアジアを拠点とする有力な投資組織、さらには既存の投資企業3社が参加しました。 今回の調達資金は、Brii Bioの広範な感染性疾患パイプラインに加え、当社の中枢神経系疾患プログラムを前進させるために使用します。 Brii Bioの最高経営責任者（CEO）であるZhi Hong博士は、次のように述べています。「2018年の設立以来、Brii Bioは提携を通じ、また高度に差別化された創薬における当社独自の洞察的知見を活用して、画期的な医薬品の開発と提供を加速するという使命に向けて、大きな前進を達成してきました。当社が世界最大級の公衆衛生上の問題や疾病負担に対処するための取り組みを行う中で、中国だけでなく世界中の患者さんのために革新的な治療薬を発見・開発・提供するという、当社の使命を共有する投資企業の支援を得られたことをうれしく、また光栄に思います。」 Brii Bioは現在、複数の感染症を対象に臨床研究を行っており、中枢神経系疾患でも臨床段階の研究に入る準備を進めています。当社のプログラムは下記の通りです。…
Powell praises economic recovery and sees Fed pulling back help after ‘substantial’ progress
Federal Reserve Chair Jerome Powell prepares for a House Financial Services Committee hearing on “Oversight of…
Ryu Games raises $2.3M, betting that cash tournaments for mobile games are the future
Ryu Games, a startup that helps developers add cash tournaments to their mobile games, announced this…
SOMERSET, N.J.–(BUSINESS WIRE)–LabVantage Solutions, Inc., il principale fornitore di soluzioni e servizi di informatica per laboratorio,…
PHOENIX, Ariz.–(BUSINESS WIRE)–VIQ Solutions Inc. (“VIQ” or the “Company”) (TSX:VQS and OTCQX:VQSLF), a global provider of…
MONTREAL e HONG KONG–(BUSINESS WIRE)–Immervision Inc. ha annunciato un nuovo collaboratore per JOYCE, il primo robot…
S&P 500 falls slightly as stock market continues March churn
The S&P 500 dipped on Thursday, continuing its volatile run in March as the rally to…
Will fading YOLO sentiment impact Robinhood, Coinbase and other trading platforms?
What happens to hot fintech startups that have benefited from a rise in consumer trading activity…